Advertisement

Topics

AbbVie's HCV drug Maviret gains approval from European Commission

05:17 EDT 1 Aug 2017 | SmartBrief

The European Commission has approved the use of AbbVie's hepatitis C treatment Maviret in Europe.  -More

Original Article: AbbVie's HCV drug Maviret gains approval from European Commission

NEXT ARTICLE

More From BioPortfolio on "AbbVie's HCV drug Maviret gains approval from European Commission"

Quick Search
Advertisement
 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Gastroenterology
Astroesophageal Reflux Disease (GERD) Barrett's Esophagus Celiac Disease Cholesterol Crohn's Disease Gastroenterology Hepatitis Hepatology Irritable Bowel Syndrome (IBS) Pancreatitis Peptic Ulcer Disease...